8
DIABETIC KETOACIDOSIS FLAME LECTURE: 9 AKACHE 10.27.18

9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

DIABETIC KETOACIDOSISFLAME LECTURE: 9AKACHE 10.27.18

Page 2: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

LEARNING OBJECTIVESu To describe Diabetic Ketoacidosis u To understand the etiology, presentation,

diagnosis, and treatmentuPrerequisites:

uNONEuSee also – for closely related topics

uFLAMEs on T1DM and T2DM and HHS

Page 3: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

WHAT IS DKA?u Complication of T1DM or ketosis-prone T2DM

u Increased Glucagon, Decreased insulin

u Hyperglycemia caused by: increased gluconeogenesis, increased glycogenolysis, decreased cellular glucose uptake

u Ketoacidosis caused by: insulin deficiency causing lipolysis, increased free fatty acids for ketogenesis, increased hepatic ketogenic state, decreased clearance of ketones

Page 4: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

ETIOLOGYu Precipitating factors (Remember the I’s!):

uInfection (pneumonia, UTI, sepsis)uInsulin deficiency (discontinued use, inadequate therapy)uIschemia (MI) or Infarction (CVA)uInflammation (pancreatitis, cholecystitis) uIatrogenic (SGLT-2 inhibitors, glucocorticoids, high dose

thiazides, dobutamine, terbutaline, 2nd genereationatypical antipsychotics)

uIntoxication (alcohol, cocaine)u Other: new onset T1DM, psychological problems (eating

disorder), malfunction of subcutaneous infusion device

Page 5: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

PRESENTATIONu Polyuria, polydipsia, and dehydration

u Tachycardia, hypotension, dry mucous membranes, decreased skin turgor

u Nausea, vomiting, abdominal pain, ileusu Kussmaul respirations (deep compensatory

hyperventilation)u Acetone “fruity” odor to breath u Mental status change

u Somnolence, stupor, coma u Neurologic findings are more common in HHS

Page 6: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

DIAGNOSISu DKA Triad:

1. Increased anion gap metabolic acidosis2. Positive urine and serum ketones3. Increased serum glucose (generally 350-500 mg/dL; usually

<800mg/dL)

u Increased BUN and creatinineu Hyponatremiau Hypo- or Hyperkalemia (total body potassium is depleted)u Decreased total body phosphorus u Leukocytosis u Increased amylase and lipase (not necessarily indicating

pancreatitis)

Page 7: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

TREATMENTu Address precipitants (infection, inflammation, ischemia, etc)u Aggressive hydration: NS 10-14 mL/kg/hru Insulin

u 10U IV push followed by 0.1u/kg/hr, continue drip until normal anion gapu Add dextrose to IVF if glucose <250 and anion gap is still increased and

continue insulin to metabolize ketonesu Subcutaneous insulin once anion gap closes (overlap IV and subcutaneous

for 2-3 hours

u Electrolyte repletionu Potassium: add 20-40mEq/L to IVF if serum K<4.5 (note that insulin promotes

cellular uptake of K+ causing decreased serum K)u Bicarb: replete if pH <7 or if cardiac instability is presentu Phosphorus: replete if <1

Page 8: 9 - DIABETIC KETOACIDOSIS (RA 10.27.18) · 2019-04-21 · LEARNING OBJECTIVES uTo describe Diabetic Ketoacidosis uTo understand the etiology, presentation, diagnosis, and treatment

REFERENCES1. Sabatine MS. Pocket Medicine. 6th Ed. The Massachusetts General

Hospital Handbook of Internal Medicine. 2017.2. Hirsch IB, Emmett M. Diabetic ketoacidosis and hyperosmolar

hyperglycemic state in adults: Epidemiology and pathogenesis. 2018.

3. Hirsch IB, Emmett M. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis. 2018. Hirsch IB, Emmett M. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment. 2018.